Concepedia

Comparing LCZ696 With Enalapril According to Baseline Risk Using the MAGGIC and EMPHASIS-HF Risk Scores

Joanne Simpson, Pardeep S. Jhund, José Silva‐Cardoso, Felipe Martínez‐Pastor, Arend Mosterd, Félix José Alvarez Ramires, Adel R. Rizkala, Michele Senni, Iain Squire, Jianjian Gong,

Journal of the American College of Cardiology · 2015 · 127 citations · 8 references

DOI

Concepts

References

8

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

John J.V. McMurray, Milton Packer, Akshay S. Desai et al. · New England Journal of Medicine · 2014 · 6.8K citations · Full text

, , +11

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

Faı̈ez Zannad, John J.V. McMurray, Henry Krum et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text

, , +4

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger et al. · The Lancet · 2003 · 1.9K citations

, , +11

Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

Milton Packer, John J.V. McMurray, Akshay S. Desai et al. · Circulation · 2014 · 667 citations · Full text

, , +16

Dual Angiotensin Receptor and Neprilysin Inhibition as an Alternative to Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale for and Design of the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure Trial (PARADIGM-HF)

John J.V. McMurray, Milton Packer, Akshay S. Desai et al. · European Journal of Heart Failure · 2013 · 452 citations · Full text

, , +17